| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |